Obesity Clinical Trial
Official title:
Popular Diets, Metabolism, and CVD Risk
| Verified date | November 2016 |
| Source | Boston Children’s Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Federal Government |
| Study type | Interventional |
The aim of this study is to evaluate the effects of three dominant dietary patterns - conventional low-fat, low-glycemic index (GI) and very-low-carbohydrate - on energy metabolism and heart disease risk factors following weight loss in obese young adults in a feeding study
| Status | Completed |
| Enrollment | 24 |
| Est. completion date | April 2013 |
| Est. primary completion date | June 2010 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 18 Years to 40 Years |
| Eligibility |
Inclusion Criteria: - BMI = 27 kg/m2 - Willing and able to come to the GCRC 5 days per week to consume a supervised meal and pick-up food for all other meals - Available for scheduled hospital admissions - Willing to abstain from alcohol consumption for the duration of the study - If female, regular menstrual cycles (defined as 26 to 30 days between cycles; no more than one day variation in the duration of menstrual flow) Exclusion Criteria: - Weight > 350 lbs - Change in body weight (± 10%) over preceding year - Taking any medications or dietary supplements that might affect body weight, appetite, or energy expenditure - Smoking (1 cigarette in the last week) - High levels of physical activity - Currently following a special diet - Abnormal laboratory screening tests - Type 2 diabetes mellitus - Allergies or aversions to foods on the study menu - Previous diagnosis of an eating disorder or any other mental health disorder - If female, pregnant in the past 12 months or planning to become pregnant during the study period - If female, lactating in the preceding 12 months - If taking birth control medication, change in medication in previous 3 months or plans to change medication during the study period |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention
| Country | Name | City | State |
|---|---|---|---|
| United States | Children's Hospital Boston | Boston | Massachusetts |
| Lead Sponsor | Collaborator |
|---|---|
| Boston Children’s Hospital | Brigham and Women's Hospital, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
Ebbeling CB, Swain JF, Feldman HA, Wong WW, Hachey DL, Garcia-Lago E, Ludwig DS. Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA. 2012 Jun 27;307(24):2627-34. doi: 10.1001/jama.2012.6607. — View Citation
Walsh CO, Ebbeling CB, Swain JF, Markowitz RL, Feldman HA, Ludwig DS. Effects of diet composition on postprandial energy availability during weight loss maintenance. PLoS One. 2013;8(3):e58172. doi: 10.1371/journal.pone.0058172. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | resting energy expenditure using indirect calorimetry in the fasting state | end of each dietary period | No | |
| Primary | insulin resistance assessed by frequently-sampled oral glucose tolerance test | end of each dietary period | No | |
| Primary | thyroid function tests | end of each dietary period | No | |
| Secondary | total energy expenditure using doubly labeled water methodology | end of each dietary period | No | |
| Secondary | thermic effect of food using indirect calorimetry | end of each dietary period | No | |
| Secondary | physical activity using accelerometry | end of each dietary period | No | |
| Secondary | serum lipids | end of each dietary period | No | |
| Secondary | plasminogen activator inhibitor-1 | end of each dietary period | No | |
| Secondary | C-reactive protein | end of each dietary period | No | |
| Secondary | blood pressure | end of each dietary period | No | |
| Secondary | hunger/appetite | end of each dietary period | No | |
| Secondary | insulin 30 minutes after oral glucose (as an effect modifier) | baseline | No | |
| Secondary | Core temperature | End of each dietary period | No | |
| Secondary | secreted frizzle-related protein-4 | end of each dietary period | No | |
| Secondary | heme-oxygenase | end of each dietary period | No | |
| Secondary | Irisin | end of each dietary period | No | |
| Secondary | fibroblast growth factor-21 | end of each dietary period | No | |
| Secondary | chemerin | end of each dietary period | No | |
| Secondary | trimethylamine N-oxide | fasting and postprandial, end of each dietary period | No | |
| Secondary | alanine aminotransferase | end of each dietary period | No | |
| Secondary | Uric acid | end of each dietary period | No | |
| Secondary | insulin | fasting and postprandial, end of each dietary period | No | |
| Secondary | ghrelin | fasting and postprandial, end of each dietary period | No | |
| Secondary | gastric inhibitory peptide | fasting and postprandial, end of each dietary period | No | |
| Secondary | GLP1 | fasting and postprandial, end of each dietary period | No | |
| Secondary | PYY | fasting and postprandial, end of each dietary period | No | |
| Secondary | Amylin | fasting and postprandial, end of each dietary period | No | |
| Secondary | Leptin | end of each dietary period | No | |
| Secondary | Metabolomic analysis | Evaluate the effect of diet on metabolomic profile in plasma, with the aim of assessing dietary adherence and exploring diet-disease mechanisms | end of each dietary period | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |